Cargando…
Risk of inpatient epistaxis admission related to oral anticoagulation medication use
We utilized a case control study to determine if novel oral anticoagulants were associated with a higher risk of inpatient epistaxis admission. Adult patients admitted with a principal diagnosis of epistaxis in 2019–2021 were identified as well as a control group of patients matched 1:1 for age, sex...
Autores principales: | Mitchell, Margaret B., Workman, Alan D., Lu, Richard, Bhattacharyya, Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10446254/ https://www.ncbi.nlm.nih.gov/pubmed/37621276 http://dx.doi.org/10.1002/lio2.1111 |
Ejemplares similares
-
The role of oral anticoagulants in epistaxis
por: Buchberger, A. M. S., et al.
Publicado: (2018) -
Weekly epistaxis duration as an indicator of epistaxis severity in hereditary hemorrhagic telangiectasia—Preliminary results from a randomized controlled trial
por: Wu, Vincent, et al.
Publicado: (2021) -
Does chronic rhinosinusitis relate to systemic hypoxemia?
por: Bhattacharyya, Neil
Publicado: (2020) -
Epistaxis
Publicado: (1909) -
Winter peaks in web-based public inquiry into epistaxis
por: Liu, David Tianxiang, et al.
Publicado: (2020)